Fixed-duration epcoritamab + R(2) drives deep and durable responses in patients with relapsed or refractory follicular lymphoma: 2-year follow-up from arm 2 of the EPCORE NHL-2 trial Meeting Abstract
| Authors: | Falchi, L.; Balari, A. S.; Leppä, S.; Vermaat, J. S. P.; Nijland, M.; Christensen, J. H.; de Vos, S.; Holte, H.; Merryman, R. W.; Lugtenburg, P.; Costa, P. A.; Linton, K.; Sunkersett, G.; Morehouse, C.; Steele, A. J.; Marek, J.; Wang, L. W.; Hoehn, D.; Hutchings, M.; Belada, D. |
| Abstract Title: | Fixed-duration epcoritamab + R(2) drives deep and durable responses in patients with relapsed or refractory follicular lymphoma: 2-year follow-up from arm 2 of the EPCORE NHL-2 trial |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 343 |
| End Page: | 344 |
| Language: | English |
| ACCESSION: | WOS:001412768200042 |
| DOI: | 10.1182/blood-2024-200262 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
